Utilising survey data to inform public policy: Comparison of the cost-effectiveness of treatment of ten mental disorders
暂无分享,去创建一个
Helen Lapsley | Gavin Andrews | Cathy Issakidis | G. Andrews | H. Lapsley | C. Issakidis | K. Sanderson | Kristy Sanderson | Justine Corry | J. Corry
[1] R. Kessler. The World Health Organization International Consorthm in Psychiatric Epidemiology (ICPE): initial work and future directions ‐ the NAPE Lecture 1998 a , 1999 .
[2] R. Rosenheck,et al. Principles for priority setting in mental health services and their implications for the least well off. , 1999, Psychiatric services.
[3] I. Hickie,et al. Summary of Guideline for the Treatment of Depression , 2003 .
[4] J. Castro. The Price of Mental Health , 1965, Time.
[5] W. Katon,et al. Depression, anxiety, and social disability show synchrony of change in primary care patients. , 1993, American journal of public health.
[6] J. Lonnqvist,et al. Antidepressant efficacy and quality of life in depression: a double‐blind study with moclobemide and fluoxetine , 1994, Acta psychiatrica Scandinavica.
[7] G. Andrews. Randomised controlled trials in psychiatry: important but poorly accepted , 1999, BMJ.
[8] G. Andrews,et al. The economic costs of schizophrenia. Implications for public policy. , 1985, Archives of general psychiatry.
[9] W. Jack. Public spending on health care: how are different criteria related? A second opinion. , 2000, Health Policy.
[10] G. Andrews,et al. Summary of Guideline for the Treatment of Panic Disorder and Agoraphobia , 2003 .
[11] C. Mihalopoulos. Assessing cost-effectiveness in mental health , 2004 .
[12] R. Warner. How much of the burden of schizophrenia is alleviated by treatment? , 2003, British Journal of Psychiatry.
[13] G. Andrews,et al. Using epidemiological data to model efficiency in reducing the burden of depression* , 2000, The journal of mental health policy and economics.
[14] M. Teesson,et al. Who seeks treatment for alcohol dependence? , 2002, Social Psychiatry and Psychiatric Epidemiology.
[15] John W. Finney,et al. Brief Interventions for Alcohol Problems , 2004, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.
[16] D M Steinwachs,et al. Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. , 1998, Schizophrenia bulletin.
[17] G. Andrews,et al. Prevalence, comorbidity, disability and service utilisation , 2001, British Journal of Psychiatry.
[18] G. Andrews,et al. Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders , 2004, Psychological Medicine.
[19] A. Maynard,et al. Rationing health care: an exploration. , 1999, Health policy.
[20] R. Goldney. Guidelines for the treatment of depression. , 2004, The Australian and New Zealand journal of psychiatry.
[21] D. Goldberg. Invited commentary on: Cost-effectiveness of current and optimal treatment for schizophrenia , 2003, British Journal of Psychiatry.
[22] D S Rae,et al. Congruence of service utilization estimates from the Epidemiologic Catchment Area Project and other sources. , 1993, Archives of general psychiatry.
[23] D Castle,et al. Psychotic Disorders in Urban Areas: An Overview of the Study on Low Prevalence Disorders , 2000, The Australian and New Zealand journal of psychiatry.
[24] G. Andrews,et al. Deconstructing current comorbidity: data from the Australian National Survey of Mental Health and Well-Being , 2002, British Journal of Psychiatry.
[25] J. Finney,et al. Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. , 2002, Addiction.
[26] G. Andrews,et al. The Treatment of Anxiety Disorders: Clinician Guides and Patient Manuals , 1995 .
[27] S. Faraone,et al. The concept of target features in schizophrenia research , 1999, Acta psychiatrica Scandinavica. Supplementum.
[28] Alan D. Lopez,et al. The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .
[29] H. Barker. Randomised controlled trials in psychiatry , 2000, BMJ : British Medical Journal.
[30] P. Musgrove. Public spending on health care: how are different criteria related? , 1999, Health policy.
[31] Alan D. Lopez,et al. The burden of disease and injury in Australia. , 2001, Bulletin of the World Health Organization.
[32] G. Andrews,et al. Using the effect size to model change in preference values from descriptive health status , 2004, Quality of Life Research.
[33] G. Andrews,et al. Evidence-based care for alcohol use disorders is affordable. , 2004, Journal of studies on alcohol.
[34] G. Andrews,et al. Cost-effectiveness of current and optimal treatment for schizophrenia , 2003, British Journal of Psychiatry.
[35] M. Mcgrath. Cost Effectiveness in Health and Medicine. , 1998 .
[36] K. Calman. The ethics of allocation of scarce health care resources: a view from the centre. , 1994, Journal of medical ethics.
[37] G. Andrews,et al. Reducing the burden of affective disorders: is evidence-based health care affordable? , 2003, Journal of affective disorders.